Federal and state healthcare policy changes affecting access, benefits, eligibility, and care delivery.
Federal agencies extended pandemic-era telehealth flexibilities for prescribing certain controlled substances, including ADHD stimulants, through December 31, 2025. Here’s what that meant, where things stand in March 2026, and how patients can avoid treatment disruptions.
Federal telehealth flexibilities allowed many ADHD stimulant prescriptions to be written without an in-person exam through December 31, 2025. Here’s what changed, where things stand in March 2026, and how patients can avoid treatment disruptions.
Federal mental health funding for 2026 places renewed focus on the 988 Suicide & Crisis Lifeline and Certified Community Behavioral Health Clinics. Here’s what that could mean for crisis response, wait times, and access to care across the United States.
Medicare’s 2026 physician payment rule changes how doctors are paid for office visits, preventive services, telehealth, and chronic care. Here’s what that could mean for appointment access, screenings, and small or rural practices.
A temporary Medicaid funding deferral in Minnesota has raised questions about coverage, provider payments, and federal oversight. Here’s what enrollees and healthcare providers should understand about how Medicaid financing works and what could happen next.
The FDA has updated its shortage listings and enforcement posture around compounded semaglutide and tirzepatide. Here’s what that could mean for patients who rely on these medications for diabetes or weight management.
New federal funding from SAMHSA in 2026 aims to strengthen crisis response, expand community mental health services, and prevent suicide. Here’s what that could mean for families, schools, and local care access across the United States.
The 2026 Medicare physician fee schedule affects how doctors are paid, which services are prioritized, and how easy it may be for patients to find care. Here’s what the latest CMS updates could mean for access, preventive services, and community health.
Starting in 2026, new federal rules require many insurers to publicly report how often they deny, approve, or delay prior authorization requests. Here’s what that could mean for patients, doctors, and access to care.
As the FDA updates its policies around compounded versions of GLP-1 drugs like semaglutide and tirzepatide, patients may see changes in availability, pricing, and oversight. Here’s what the shift means for access, safety, and insurance coverage.
Staffing shortages across hospitals, clinics, nursing homes, and dental offices continue to shape how Americans access care. Here’s what federal data and recent reports show—and what it means for patients.
Vaccines are recommended by expert panels, covered by most insurance plans, and provided at low or no cost through federal programs—but access can still be confusing. Here’s how U.S. immunization policy works and what it means for you and your family.
Medicare beneficiaries are seeing continued changes to prescription drug costs, Medicare Advantage rules, and payment policies in 2026. Here’s what the latest CMS updates mean for your coverage, out-of-pocket costs, and access to care.
Medicaid and the Children’s Health Insurance Program (CHIP) cover more than 90 million Americans. Here’s what’s changed recently, how renewals work, and what families should watch for in 2026.
End of content
End of content